Search Results
Dr. Chan Discusses Cabozantinib for the Treatment of NETs
Dr. Chan Discusses the Results of the CABINET Trial/Cabozantinib as a New Effective Treatment
Dr. Chan on Trial of Cabozantinib in Neuroendocrine Tumors
Dr. Kulke on Emerging Cabozantinib Data for NETs
Treatments on the Horizon in NETs
New Ways to Treat NETs - Blase Polite
Introduction to NETs, Jennifer Chan MD, MPH, Dana-Farber
Dr. Helft Discusses Pancreatic and Carcinoid NETs
Neuroendocrine Tumor Guidelines
"TKIs: Tyrosine Kinase Inhibitors & Neuroendocrine Tumors" • 2024 LACNETS Event • March 29, 2024
For Patients: Being Aware of Possible Side Effects With CABOMETYX® (cabozantinib)
Emerging Therapies in Neuroendocrine Tumors (NETs)
